diabetic foot ulcer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with diabetic foot infection with an infected wound; 2.Age >=18 years old, male or female; 3.It can provide sufficient infected wound samples (>=5mm^3 infected wound tissue samples or >=100µL infected wound secretions) and can be used for detection and analysis of gene chips; 4.No history of antibiotic therapy prior to sampling (within 4 weeks) or known failure to respond to antibiotic therapy (failure to respond to >=2 antibiotics); 5.Fully understand the nature, significance, possible benefits, possible inconveniences or potential risks of this research; Understand the study procedure, participate voluntarily and be willing to complete the entire study process, and sign the informed consent;
Exclusion criteria
Exclusion criteria: 1.Patients with undiagnosed diabetic foot infection; 2.Patients who had received antibiotics within 4 weeks prior to sampling; 3.Complicated with serious systemic disease (e.g., malignant tumor, severe cardiopulmonary insufficiency, etc.); 4.Pregnant or lactating women; 5.Cognitive impairment or inability to cooperate with the research process; 6.History of allergies or allergies to materials related to the study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity;positive predictive value;negative predictive value;specificity; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cure rate;Recurrence rate; | — |
Countries
China
Contacts
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine